Skip to content

REVOLVE or PureGraft Technique in Processing Fat Grafts for Patients Undergoing Breast Reconstruction

A Randomized, Prospective Comparison of Methods to Process Autologous Fat Grafts in Breast Reconstruction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03502512
Enrollment
20
Registered
2018-04-18
Start date
2018-02-13
Completion date
2021-08-06
Last updated
2021-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mammoplasty Patient

Brief summary

This trial studies how well REVOLVE or PureGraft technique works in processing fat grafts for patients who are undergoing breast reconstruction. During breast reconstructive surgery that uses autologous fat grafting (transplanting fat tissue from one part of your body to another), fat tissue is removed from the body (usually the abdomen, buttock, or thighs) and injected into another part of the body. This tissue must be processed (sometimes referred to as washed or prepared) before being inserted back into the body. It is not yet known whether REVOLVE or PureGraft technique may work better in retaining graft fat after surgery.

Detailed description

PRIMARY OBJECTIVES: I. To measure and compare the rate of fat graft retention, defined as the rate between the volume of fat remaining in the surgical site at one year and the volume of fat at baseline, associated with the use of two aforementioned adipose tissue processing techniques. SECONDARY OBJECTIVES: I. To measure early post-operative complications including infection, hematoma, delayed wound healing or seroma. II. To measure late complications associated with fat grafting including fat necrosis, cyst formation, palpable mass, or breast asymmetry. III. To measure patient reported outcomes (PRO, BREAST-Questionnaire \[Q\], Body Image Survey). OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients undergo reconstructive surgery with REVOLVE technique. ARM II: Patients undergo reconstructive surgery with PureGraft technique. After completion of study, patients are followed up at 2-4 weeks and then once a year for up to 2 years.

Interventions

OTHERQuestionnaire Administration

Ancillary studies

PROCEDUREReconstructive Surgery

Undergo reconstructive surgery with REVOLVE technique

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Previous breast surgery, either mastectomy or partial mastectomy * Patients with available harvest sites for fat grafting * Patients with body mass index (BMI) \> 20 * Anticipated harvested fat volume \> 100 cc * Patients are willing and able to give consent

Exclusion criteria

* Patients with active cancer, including primary cancer, recurrent cancer and locally or distantly metastatic cancer * Patients who are unable to provide consent * Patients who are suspected or known to be pregnant

Design outcomes

Primary

MeasureTime frameDescription
Fat graft retention rateAt 1 yearRate of fat graft retention, defined as the rate between the volume of fat remaining in the surgical site at one year and the volume of fat at baseline, associated with the use of the REVOLVE and PureGraft tissue processing techniques.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026